Skip to main content

Quality of Care Indicators in Pancreatic Cancer

  • 1449 Accesses

Abstract

Quality of care is defined by a range of dimensions (safe, effective, efficient, timely, patient-centred and equitable care) and components (structure, process, outcome). From a clinical perspective, quality of care is measured through the development of core-sets of quality indicators that is based on current evidence and best practice. In addition, Patient-Reported Outcome Measures (PROMs) are equally important in understanding a patient’s perspective on their wellbeing, functional status and health-related quality of life. The latter is an important consideration in values-based healthcare. To achieve optimal care in pancreatic cancer which is characterised by poor survival, high symptom and psychological burden, care needs to be monitored using the above described measures, then evaluated to identify variations that exist and reported back to relevant stakeholders within a framework of a continuous quality improvement cycle.

Keywords

  • Quality of care
  • Quality indicators
  • Pancreatic cancer
  • PROMs
  • Value-based health

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-030-53786-9_6
  • Chapter length: 15 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-3-030-53786-9
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.99
Price excludes VAT (USA)
Hardcover Book
USD   199.99
Price excludes VAT (USA)
Fig. 6.1
Fig. 6.2
Fig. 6.3
Fig. 6.4

References

  1. Institute of Medicine (US) Committee to Design a Strategy for Quality Review and Assurance in Medicare. Chapter 5, Defining quality of care. In: Medicare: a strategy for quality assurance, vol. II. Sources and methods. Washington, DC: National Academies Press (US); 1990.

    Google Scholar 

  2. Institute of Medicine Committee on Quality of Health Care in A. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press (US) . Copyright 2001 by the National Academy of Sciences. All rights reserved.; 2001.

    Google Scholar 

  3. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3 Suppl):166–206.

    CrossRef  Google Scholar 

  4. Branch-Elliman W, O’Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg. 2019;154(7):590–8.

    CrossRef  Google Scholar 

  5. Coster WJ. Making the best match: selecting outcome measures for clinical trials and outcome studies. Am J Occup Ther. 2013;67(2):162–70.

    CrossRef  Google Scholar 

  6. Lane-Fall MB, Neuman MD. Outcomes measures and risk adjustment. Int Anesthesiol Clin. 2013;51(4):10–21.

    Google Scholar 

  7. Kutlu OC, Lee JE, Katz MH, Tzeng CD, Wolff RA, Varadhachary GR, et al. Open pancreaticoduodenectomy case volume predicts outcome of laparoscopic approach: a population-based analysis. Ann Surg. 2018;267(3):552–60.

    CrossRef  Google Scholar 

  8. Gooiker GA, van Gijn W, Wouters MW, Post PN, van de Velde CJ, Tollenaar RA. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg. 2011;98(4):485–94.

    CAS  CrossRef  Google Scholar 

  9. Urbach DR. Pledging to eliminate low-volume surgery. N Engl J Med. 2015;373(15):1388–90.

    CAS  CrossRef  Google Scholar 

  10. Torgeson A, Garrido-Laguna I, Tao R, Cannon GM, Scaife CL, Lloyd S. Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. ESMO Open. 2018;3(1):e000282.

    CrossRef  Google Scholar 

  11. Apollos JR, Sami S, Prasanth MN, Jeyakumar J, McFadyen AK. Pre-diagnostic delays caused by gastrointestinal investigations do not affect outcomes in pancreatic cancer. Ann Med Surg. 2018;34:66–70.

    CrossRef  Google Scholar 

  12. Martin HL, Ohara K, Chin W, Davidson A, Bayliss E, Redfern A, et al. Cancer services in Western Australia: a comparison of regional outcomes with metropolitan Perth. Aust J Rural Health. 2015;23(5):302–8.

    CrossRef  Google Scholar 

  13. Burmeister EA, O’Connell DL, Jordan SJ, Goldstein D, Merrett N, Wyld DK, et al. Factors associated with quality of care for patients with pancreatic cancer in Australia. Med J Aust. 2016;205(10):459–65.

    CrossRef  Google Scholar 

  14. Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK, et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology. 2009;41(2):161–7.

    CrossRef  Google Scholar 

  15. Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy. 2015;119(4):464–74.

    CrossRef  Google Scholar 

  16. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15(6):523–30.

    CrossRef  Google Scholar 

  17. Prosser-Snelling E, Morris E. Quality indicators. Obstetr Gynaecol Reprod Med. 2017;27(9):290–2.

    CrossRef  Google Scholar 

  18. Deming WE. Out of the crisis. Cambridge, MA: MIT Press; 2000.

    Google Scholar 

  19. Taylor MJ, McNicholas C, Nicolay C, Darzi A, Bell D, Reed JE. Systematic review of the application of the plan–do–study–act method to improve quality in healthcare. BMJ Qual Saf. 2014;23(4):290.

    CrossRef  Google Scholar 

  20. Dalkey NC. The Delphi method: an experimental study of group opinion. Santa Monica, CA: RAND Corp; 1969.

    Google Scholar 

  21. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND Corp; 2001.

    Google Scholar 

  22. Bilimoria KY, Bentrem DJ, Lillemoe KD, Talamonti MS, Ko CY, On behalf of the American College of Surgeons’ Pancreatic Cancer Quality Indicator Development Expert P. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst. 2009;101(12):848–59.

    CrossRef  Google Scholar 

  23. Burmeister EA, Jordan SJ, O’Connell DL, Beesley VL, Goldstein D, Gooden HM, et al. Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia Pac J Clin Oncol. 2016;12(2):105–14.

    CrossRef  Google Scholar 

  24. Maharaj AD, Ioannou L, Croagh D, Zalcberg J, Neale RE, Goldstein D, et al. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. HPB (Oxford). 2019;21(4):444–55.

    CrossRef  Google Scholar 

  25. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.

    CrossRef  Google Scholar 

  26. Corbellini C, Andreoni B, Ansaloni L, Sgroi G, Martinotti M, Scandroglio I, et al. Reliability and validity assessment of administrative databases in measuring the quality of rectal cancer management. Tumori J. 2018;104(1):51–9.

    CrossRef  Google Scholar 

  27. Lordick F, On behalf of the EGC, Mariette C, On behalf of the EGC, Haustermans K, On behalf of the EGC, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2016;27(Suppl 5):v50–7.

    Google Scholar 

  28. Porter ME, Kaplan RS, Frigo ML. Managing healthcare costs and value. Strategic Finance. 2017;98(7):24.

    Google Scholar 

  29. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81.

    CAS  CrossRef  Google Scholar 

  30. Gerritsen A, Jacobs M, Henselmans I, van Hattum J, Efficace F, Creemers G-J, et al. Developing a core set of patient-reported outcomes in pancreatic cancer: a Delphi survey. Eur J Cancer. 2016;57:68–77.

    CrossRef  Google Scholar 

  31. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27.

    CrossRef  Google Scholar 

  32. Beesley VL, Janda M, Goldstein D, Gooden H, Merrett ND, O’Connell DL, et al. A tsunami of unmet needs: pancreatic and ampullary cancer patients’ supportive care needs and use of community and allied health services. Psychooncology. 2016;25(2):150–7.

    CrossRef  Google Scholar 

  33. Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305–14.

    CrossRef  Google Scholar 

  34. Maharaj AD, Samoborec S, Evans SM, Zalcberg J, Neale RE, Goldstein D, Merrett N, White K, Croagh D, Pilgrim CHC, Evans P, Knowles B, Leong T, Philip J, Smith M, Ioannou L. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. HPB (Oxford). 2019;22(2):187–203.

    CrossRef  Google Scholar 

  35. Wilcox N, McNeil JJ. Clinical quality registries have the potential to drive improvements in the appropriateness of care. Med J Aust. 2016;205(S10):S21–S6.

    CrossRef  Google Scholar 

  36. Sherman S, Shats O, Ketcham MA, Anderson MA, Whitcomb DC, Lynch HT, et al. PCCR: pancreatic cancer collaborative registry. Cancer Informat. 2011;10:83–91.

    Google Scholar 

  37. Fristrup C, Detlefsen S, Hansen CP, Ladekarl M. Danish pancreatic cancer database. Clin Epidemiol. 2016;8:645–8.

    CrossRef  Google Scholar 

  38. Maharaj AD, Holland JF, Scarborough R, Evans SM, Ioannou L, Brown WA, Croagh D, Pilgrim CHC, Kench JG, Lipton LR, Leong T, McNeil JJ, Nikfarjam M, Aly A, Burton PR, Cashin PA, Chu J, Duong C, Evans P, Goldstein D, Haydon A, Hii MW, Knowles BPF, Merrett N, Michael M, Neale RE, Philip J, Porter IWT, Smith M, Spillane J, Tagkalidis PP, Zalcberg J. Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers. BMJ Open. 2019;9(9):e031434.

    CrossRef  Google Scholar 

  39. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;(6):CD000259.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sue M. Evans .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Maharaj, A.D., Zalcberg, J.R., Ioannou, L.J., Croagh, D., Evans, S.M. (2021). Quality of Care Indicators in Pancreatic Cancer. In: Søreide, K., Stättner, S. (eds) Textbook of Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-53786-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53786-9_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53785-2

  • Online ISBN: 978-3-030-53786-9

  • eBook Packages: MedicineMedicine (R0)